Baader Bank Aktiengesellschaft decreased its holdings in Boston Scientific Corporation (NYSE: BSX) b

Andra AP fonden lifted its holdings in Boston Scientific Corporation (NYSE: BSX) by 144.4% in the un

Bessemer Group Inc. reduced its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 9

Boston Scientific (BSX) reached $43.19 at the closing of the latest trading day, reflecting a -1.33%

US equities advanced during Q2, supported by another quarter of better-than-expected corporate earni

BSX faces Q2 results with growth expected in key businesses, but lowered full-year guidance, cost pr

Allspring Global Investments Holdings LLC reduced its holdings in shares of Boston Scientific Corpor

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and

Mizuho analyst Anthony Petrone maintains Boston Scientific (NYSE:BSX) with a Outperform and lower

In the latest trading session, Boston Scientific (BSX) closed at $42.63, marking a -4.52% move from

RBC Capital analyst Shagun Singh maintains Boston Scientific (NYSE:BSX) with a Outperform and low

The recommendations of Wall Street analysts are often relied on by investors when deciding whether t

A sharp rotation trade has taken over markets to start the second half of 2026, with investors dumpi

July brings a sharp rotation trade in markets as investors shift from top performers to beaten-down

Amazon and Nvidia have been caught up in the AI trade, but have flatlined so far in 2026. Steve Cohe

Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric

Boston Scientific (BSX) closed at $44.6 in the latest trading session, marking a -1.2% move from the

Relative to its all-time high of $109.50 reached in September 2025, Boston Scientific Corporation's

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform a

In the most recent trading session, Boston Scientific (BSX) closed at $42.68, indicating a -1.84% sh

Boston Scientific has suffered a 50% share price decline amid decelerating growth and competitive th

Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price t

In the most recent trading session, Boston Scientific (BSX) closed at $44.46, indicating a -2.5% shi

Jefferies analyst Matthew Taylor maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the

The latest trading day saw Boston Scientific (BSX) settling at $45.6, representing a +2.86% change f

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or H

Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.07% on an annua

Jim Cramer recommends buying SOFI, and avoiding RIVN and BSX. He also says NIOBF is too speculative,

Boston Scientific (BSX) closed the most recent trading day at $44.95, moving 4.2% from the previous

Boston Scientific's shares have fallen over 50% year to date as the medtech company continues to wal

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and

BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric

Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and

Weak guidance, analyst target cuts and declining energy prices weighed on Zscaler, AutoZone, PDD Hol

Wall Street analysts change outlook on top names. For all rating changes, see analyst ratings page.

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the

Leerink Partners analyst Mike Kratky maintains Boston Scientific (NYSE:BSX) with a Outperform and

Wall Street analysts changed outlook on RLJ and Boston Scientific, with downgrades and raised price

Barclays analyst Matt Miksic maintains Boston Scientific (NYSE:BSX) with a Overweight and lowers

Wells Fargo analyst Larry Biegelsen downgrades Boston Scientific (NYSE:BSX) from Overweight to Eq

Dow notches fresh all-time high while Nasdaq 100 drops 0.7% as chip stocks unwind. Oil sinks nearly

Boston Scientific reported positive FRACTURE trial results for its SEISMIQ 4CE coronary IVL catheter

Wall Street analysts updated ratings for top stocks. Guggenheim lowered price target for Elastic, Mo

Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardi

Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers t

Boston Scientific invested $1.5 billion in MiRus and secured an option to acquire its investigationa

B of A Securities analyst Bob Hopkins maintains Boston Scientific (NYSE:BSX) with a Buy and lower

Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into an accelerated sha

Boston Scientific Corporation (NYSE:BSX) today announced it has invested $1.5 billion in return for